

Natco Pharma Profile
Key Indicators
- Authorised Capital ₹ 40.00 Cr
- Paid Up Capital ₹ 35.82 Cr
- Company Age 43 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 520.00 Cr
- Satisfied Charges ₹ 1,277.71 Cr
- Revenue Growth 30.83%
- Profit Growth 358.02%
- Ebitda 296.57%
- Net Worth 12.17%
- Total Assets 8.23%
About Natco Pharma
Natco Pharma Limited (NPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 19 September 1981 and has a history of 43 years and five months. Its registered office is in Hyderabad, Telangana, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524816 and on the National Stock Exchange(NSE) under NATCOPHARM.
The Corporate was formerly known as Natco Fine Pharmaceuticals Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 40.00 Cr and a paid-up capital of Rs 35.82 Cr.
The company currently has active open charges totaling ₹520.00 Cr. The company has closed loans amounting to ₹1,277.71 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Natco Pharma Limited India are S Rao as CFO and Venkat Chekuri as Company Secretary. Lakshminarayana Bolisetty, Agnihotra Chavali, Nitin Jain, and Six other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L24230TG1981PLC003201
- Company No.
003201
- Stock Symbol
BSE : 524816 NSE : NATCOPHARM
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 Sep 1981
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Hyderabad
Industry
What products or services does Natco Pharma Limited offer?
Natco Pharma Limited offers a wide range of products and services, including Common Disease Medicines, Steroid, Pain Relief Drugs & Pharmaceuticals, Pain Killers.
Who are the key members and board of directors at Natco Pharma?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Venkaiah Nannapaneni ![]() | Managing Director | 01-Apr-2015 | Current |
S Rao ![]() | CFO | 11-Feb-2016 | Current |
Venkat Chekuri | Company Secretary | 01-Apr-2022 | Current |
Board Members (8)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Lakshminarayana Bolisetty ![]() | Director | 12-Aug-2024 | Current |
Agnihotra Chavali ![]() | Director | 01-Apr-2024 | Current |
Nitin Jain ![]() | Director | 12-Aug-2024 | Current |
Rajeev Nannapaneni ![]() | Whole-Time Director | 01-Jun-2012 | Current |
Kantipudi Suma ![]() | Director | 12-Aug-2024 | Current |
Potluri Sivaramakrishna ![]() | Whole-Time Director | 12-Nov-2014 | Current |
Financial Performance of Natco Pharma.
Natco Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 30.83% increase. The company also saw a substantial improvement in profitability, with a 358.02% increase in profit. The company's net worth Soared by an impressive increase of 12.17%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Natco Pharma?
In 2022, Natco Pharma had a promoter holding of 48.81% and a public holding of 51.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Mahathi Infra Services Private Limited
Lakshminarayana Bolisetty is a mutual person
- B2b Software Technologies Limited
Lakshminarayana Bolisetty is a mutual person
- B.N. Rathi Securities Limited
Lakshminarayana Bolisetty is a mutual person
- Kalyan Jewellers India Limited
Agnihotra Chavali is a mutual person
- Pokarna Limited
Agnihotra Chavali is a mutual person
- Indian Immunologicals Limited
Agnihotra Chavali is a mutual person
Charges (Loans)
₹520.00 Cr
₹1,277.71 Cr
Charges Breakdown by Lending Institutions
- Others : 520.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
08 Mar 2011 | Others | ₹520.00 Cr | Open |
18 Oct 2016 | Others | ₹50.00 Cr | Satisfied |
22 Jun 2015 | Citi Bank N.A. | ₹12.05 Cr | Satisfied |
22 Dec 2014 | Citi Bank N.A. | ₹60.00 Cr | Satisfied |
10 May 2012 | Icici Bank Limited | ₹40.00 Cr | Satisfied |
How Many Employees Work at Natco Pharma?
Natco Pharma has a workforce of 4466 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Natco Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Natco Pharma's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Natco Pharma
Recent activity within the organization
- Annual General Meeting
Natco Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Director Appointment
Lakshminarayana Bolisetty was appointed as a Director was appointed as a Director on 12 Aug 2024 & has been associated with this company since 7 months 5 days .
- Director Appointment
Nitin Rameshwar Jain was appointed as a Director was appointed as a Director on 12 Aug 2024 & has been associated with this company since 7 months 5 days .
- Director Appointment
Kantipudi Suma was appointed as a Director was appointed as a Director on 12 Aug 2024 & has been associated with this company since 7 months 5 days .
- Director Appointment
Agnihotra Dakshina Murty Chavali was appointed as a Director was appointed as a Director on 01 Apr 2024 & has been associated with this company since 11 months 16 days .
- Director Appointment
Vijayabhaskar Dronadula was appointed as a Director was appointed as a Director on 01 Apr 2024 & has been associated with this company since 11 months 16 days .
Recent News, Updates & Announcement
Frequently asked questions
What is the Incorporation or founding date of Natco Pharma Limited?
Natco Pharma Limited was incorporated on 19 Sep 1981.
What is authorized share capital and paid-up capital of Natco Pharma Limited?
The authorized share capital of Natco Pharma Limited is ₹ 40.00 Cr and paid-up capital is ₹ 35.82 Cr.
Who are the current board members & directors of Natco Pharma Limited?
Currently 11 directors are associated with Natco Pharma Limited.
- Lakshminarayana Bolisetty
- Agnihotra Dakshina Murty Chavali
- Nitin Rameshwar Jain
- Venkaiah Chowdary Nannapaneni
- Rajeev Nannapaneni
- Kantipudi Suma
- Potluri Prasad Sivaramakrishna
- Lingarao Donthineni
- Vijayabhaskar Dronadula
- S V V N Appa Rao
- Venkat Ramesh Chekuri
What is the registered address of Natco Pharma Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Natco Pharma Limited is Natco House Road No.2, Banjara Hills India, Hyderabad, Telangana, 500034.
What is the corporate identification number (CIN) and company number of Natco Pharma Limited?
The corporate identification number (CIN) of Natco Pharma Limited is L24230TG1981PLC003201 and the company number is 003201 as per Ministry of Corporate Affairs (MCA).
Is Natco Pharma Limited registered with any stock exchange in India?
Yes, Natco Pharma Limited is registered on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE): NATCOPHARM.
What is the official website of Natco Pharma Limited?
The Official website of Natco Pharma Limited is https://www.natcopharma.co.in
What has been the recent revenue trend for Natco Pharma Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Natco Pharma Limited has risen by 30.83%.
How many employees does Natco Pharma Limited currently have?
As Per 2023 financial reports, 4466 employees are currently employed by Natco Pharma Limited.
What change has been observed in the net worth of Natco Pharma Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Natco Pharma Limited has experienced an upsurge of 12.17%.
What are the total open charges for Natco Pharma Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Natco Pharma Limited amount to ₹ 520.00 Cr.
When was the last Balance Sheet of Natco Pharma Limited filed with the ROC?
The most recent Balance Sheet for Natco Pharma Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
- Tarun KhannaAlternate Director
- Venkateswara ThallapakaDirector
- Nitin DeshmukhAdditional Director
- Mukul SarkarNominee Director
- Ravindranath MenonNominee Director
GD
Govinda DasuDirectorGP
Ganapati PavanWhole-Time DirectorLD
Leela DigumartiDirector